Resources
Practice resources
Product Information, patient education materials, and other resources.
Patient Information
Patient information on Multiple Myeloma, Products, and patient resources like financial support and and copay cards.
OncExpert
onExpert Multiple Myeloma provides access to the latest information on Standard of Care, Clinical Trials, Targeted Agents, and Emerging Science
Myeloma News
Powered By:
- Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA
- Bristol Myers, Bluebird Submit Biologics License Application for Idecabtagene Vicleucel
- In Virtual Meeting, CHMP Backs Sanofi’s Myeloma Drug Sarclisa
- Subcutaneous Daratumumab Is Not Inferior To Intravenous In Relapsed Or Refractory Multiple Myeloma
- Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-class Refractory Multiple Myeloma Patients From the Pivotal HORIZON Study
- SITC Cancer Immunotherapy Guidelines – Open Comment Period